Dr. Natalie Debolske, MD

Dr. Debolske practices at Surgeon's Cosmetic Center & Medspa LLC in Miami, Florida.

Dr. Debolske's NPI, 1134744683, was assigned on June 10, 2020. Dr. Debolske graduated from Baylor College Of Medicine in 2020. Dr. Debolske holds Florida license ME168968.

Dr. Debolske's primary practice is Surgeon's Cosmetic Center & Medspa LLC, at 8585 Sunset Dr, Miami, FL 33143 in Miami-Dade County. The practice phone is (305) 274-3393.

Dr. Debolske's primary practice is Surgeon's Cosmetic Center & Medspa LLC in Miami, Florida. Dr. Debolske is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Debolske to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Debolske practices, 3 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Debolske's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Debolske is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Debolske's licenses on file in 2 states: Florida and Alabama.

CMS data shows 14 Medicare services from Dr. Debolske across 1 procedure code in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $1,141 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Debolske in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Debolske's median patient age at 61, with 56% women.

In 2024, Dr. Debolske wrote 654 Medicare Part D claims for 347 patients. 68% of them were for generic drugs. CMS names the drug for 576 of them, across 11 drugs with 11 or more claims each, at $27,336 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Debolske for performance year 2024, reported as part of a group. Dr. Debolske accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Debolske, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Debolske in 2018. Dr. Debolske's most frequent co-authors are Paul F. Austin, MD, Edmond T. Gonzales, MD and Nicolette Krijgers Janzen, MD.

CMS Open Payments shows 46 general payments to Dr. Debolske from 16 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 97% of the total. Alcon Laboratories Inc paid the most, $1,063.

Dr. Debolske graduated from Baylor College Of Medicine in 2020.

Dr. Debolske is in network with 9 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.